Therapeutic potential of chemically modified siRNA: Recent trends

Chem Biol Drug Des. 2017 Nov;90(5):665-678. doi: 10.1111/cbdd.12993. Epub 2017 May 16.

Abstract

Small interfering RNAs (siRNAs) are one of the valuable tools to investigate the functions of genes and are also used for gene silencing. It has a wide scope in drug discovery through in vivo target validation. siRNA therapeutics are not optimal drug-like molecules due to poor bioavailability and immunogenic and off-target effects. To overcome the challenges associated with siRNA therapeutics, identification of appropriate chemical modifications that improves the stability, specificity and potency of siRNA is essential. This review focuses on the various chemical modifications and their implications in siRNA therapy.

Keywords: chemically modified siRNA; siRNA binding; siRNA therapeutics.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Immunomodulation
  • Molecular Docking Simulation
  • Phosphates / chemistry
  • RNA Interference
  • RNA, Small Interfering / chemistry*
  • RNA, Small Interfering / immunology
  • RNA, Small Interfering / metabolism
  • RNA, Small Interfering / therapeutic use*
  • RNAi Therapeutics
  • Ribose / chemistry

Substances

  • Phosphates
  • RNA, Small Interfering
  • Ribose